Skip to main content

Peer Review reports

From: pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

Original Submission
13 Feb 2014 Submitted Original manuscript
13 Feb 2014 Author responded Author comments - Stefan Boeck
Resubmission - Version 2
13 Feb 2014 Submitted Manuscript version 2
27 May 2014 Reviewed Reviewer Report - Santiago Aparo
9 Jun 2014 Reviewed Reviewer Report - Tanios Bekaii-Saab
19 Jun 2014 Author responded Author comments - Stefan Boeck
Resubmission - Version 3
19 Jun 2014 Submitted Manuscript version 3
20 Jul 2014 Reviewed Reviewer Report - Tanios Bekaii-Saab
6 Aug 2014 Author responded Author comments - Stefan Boeck
Resubmission - Version 4
6 Aug 2014 Submitted Manuscript version 4
11 Aug 2014 Author responded Author comments - Stefan Boeck
Resubmission - Version 5
11 Aug 2014 Submitted Manuscript version 5
14 Aug 2014 Author responded Author comments - Stefan Boeck
Resubmission - Version 6
14 Aug 2014 Submitted Manuscript version 6
Publishing
19 Aug 2014 Editorially accepted
28 Aug 2014 Article published 10.1186/1471-2407-14-624

You can find further information about peer review here.

Back to article page